GBT Is Aiming Implementation Of Blood Glucose Monitoring Feature – qTerm Device

0
35

SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”, or the “Company”) is aiming to implement a noninvasive blood glucose monitoring feature for its qTerm device. The qTerm device currently measures body temperature, blood oxygen and heart rate vitals, and plans to include blood pressure in a future release, if successfully developed.

The company plans to use a non-invasive, photoplethysmographic (PPG) optical sensors. This optical sensor technology can track small variations in blood biological substances through the skin and with the use of AI algorithms determine blood sugar levels. GBT is now running feasibility simulations to assess accuracy and options. GBT is already using optical sensors in its qTerm device to measure heart rate, and blood oxygen levels and plans to use this light sensing technology to monitor glucose levels.

A major key component for accurately measuring blood sugar levels is a machine learning algorithm that will continuously be monitoring blood changes and run analytics to produce these results. The results will be shown on a mobile and synchronized web application. The system will record the data and keep history as part of its health monitoring feature and in case of a concern the system will alert the user, and the data could be sent to a clinic or a physician through the internet for further evaluation. GBT believes that such a feature could be a significant addition to qTerm device making it a comprehensive, personal health watching system. qTerm can be used independently or as a telemedicine device enabling high quality medicine around the world.

“We are quite ambitions when it comes to our qTerm health watching device and constantly looking how to make it more comprehensive and efficient. Using the device optical sensors along with advanced artificial intelligence analytics, we are aiming to provide noninvasive blood glucose data simply with the touch of a finger. The hardware will sample blood elements data, providing it to a set of AI algorithms to conclude glucose levels. We believe this type of check, assuming fully developed, will be very appealing for diabetic patients due to its simplicity and noninvasive fashion. We strongly believe that this additional feature, if successfully developed, can be a major asset to qTerm, making it a comprehensive health watching device to assist with a healthy lifestyle,” said Danny Rittman, the Company CTO.

There is no guarantee that the Company will be successful in researching, developing or implementing this additional feature to the existing system. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval (as needed, if needed), the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.

About Us

GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.

Forward-Looking Statements

Certain statements contained in this press release may constitute “forward-looking statements”. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products. The forward-looking statements included in this press release represent the Company’s views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of the press release.

Contact:

Dr. Danny Rittman, CTO
press@gopherprotocol.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here